<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;v=2.17.9.post6+86293ac&amp;ff=20230818203338&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;v=2.17.9.post6+86293ac&amp;ff=20230818203338&amp;utm_campaign=pubmed-2&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sat, 19 Aug 2023 00:33:39 +0000</lastbuilddate>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>JAMA Network Call for Papers on Health and the 2024 US Election</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37594888/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 18. doi: 10.1001/jamacardio.2023.2857. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37594888/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37594888</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2857>10.1001/jamacardio.2023.2857</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37594888</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alison Galbraith</dc:creator>
<dc:creator>Annette Flanagin</dc:creator>
<dc:creator>Aaron E Carroll</dc:creator>
<dc:creator>John Z Ayanian</dc:creator>
<dc:creator>Robert O Bonow</dc:creator>
<dc:creator>Neil Bressler</dc:creator>
<dc:creator>Dimitri Christakis</dc:creator>
<dc:creator>Mary L Nora Disis</dc:creator>
<dc:creator>Sharon K Inouye</dc:creator>
<dc:creator>Andrew Josephson</dc:creator>
<dc:creator>Dost Öngür</dc:creator>
<dc:creator>Jay F Piccirillo</dc:creator>
<dc:creator>Kanade Shinkai</dc:creator>
<dc:creator>Kirsten Bibbins-Domingo</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>JAMA Network Call for Papers on Health and the 2024 US Election</dc:title>
<dc:identifier>pmid:37594888</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2857</dc:identifier>
</item>
<item>
<title>Optical Control of Cardiac Rhythm by In Vivo Photoactivation of an ERG Channel Peptide Inhibitor</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37593901/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18. doi: 10.1161/CIRCRESAHA.123.322880. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37593901/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37593901</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322880>10.1161/CIRCRESAHA.123.322880</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37593901</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jérôme Montnach</dc:creator>
<dc:creator>Hugo Millet</dc:creator>
<dc:creator>Antoine Persello</dc:creator>
<dc:creator>Hervé Meudal</dc:creator>
<dc:creator>Stephan De Waard</dc:creator>
<dc:creator>Pietro Mesrica</dc:creator>
<dc:creator>Barbara Ribeiro</dc:creator>
<dc:creator>Jérémie Richard</dc:creator>
<dc:creator>Agnès Hivonnait</dc:creator>
<dc:creator>Agnès Tessier</dc:creator>
<dc:creator>Benjamin Lauzier</dc:creator>
<dc:creator>Flavien Charpentier</dc:creator>
<dc:creator>Matteo E Mangoni</dc:creator>
<dc:creator>Céline Landon</dc:creator>
<dc:creator>Chris Jopling</dc:creator>
<dc:creator>Michel De Waard</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Optical Control of Cardiac Rhythm by In Vivo Photoactivation of an ERG Channel Peptide Inhibitor</dc:title>
<dc:identifier>pmid:37593901</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322880</dc:identifier>
</item>
<item>
<title>Physical activity patterns and cardiovascular health: 'yes, weekend!'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592862/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad520. doi: 10.1093/eurheartj/ehad520. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592862/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37592862</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad520>10.1093/eurheartj/ehad520</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592862</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Physical activity patterns and cardiovascular health: 'yes, weekend!'</dc:title>
<dc:identifier>pmid:37592862</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad520</dc:identifier>
</item>
<item>
<title>Ready for rapid rule-out of acute myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592857/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad519. doi: 10.1093/eurheartj/ehad519. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592857/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37592857</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad519>10.1093/eurheartj/ehad519</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592857</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Goaris W A Aarts</dc:creator>
<dc:creator>Cyril Camaro</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ready for rapid rule-out of acute myocardial infarction</dc:title>
<dc:identifier>pmid:37592857</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad519</dc:identifier>
</item>
<item>
<title>End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592821/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093/eurheartj/ehad511. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: For patients with congenitally corrected transposition of the great arteries (ccTGA), factors associated with progression to end-stage congestive heart failure (CHF) remain largely unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This multicentre, retrospective cohort study included adults with ccTGA seen at a congenital heart disease centre. Clinical data from initial and most recent visits were obtained. The composite primary outcome was mechanical circulatory support, heart transplantation, or death.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: From 558 patients (48% female, age at first visit 36 ± 14.2 years, median follow-up 8.7 years), the event rate of the primary outcome was 15.4 per 1000 person-years (11 mechanical circulatory support implantations, 12 transplantations, and 52 deaths). Patients experiencing the primary outcome were older and more likely to have a history of atrial arrhythmia. The primary outcome was highest in those with both moderate/severe right ventricular (RV) dysfunction and tricuspid regurgitation (n = 110, 31 events) and uncommon in those with mild/less RV dysfunction and tricuspid regurgitation (n = 181, 13 events, P &lt; .001). Outcomes were not different based on anatomic complexity and history of tricuspid valve surgery or of subpulmonic obstruction. New CHF admission or ventricular arrhythmia was associated with the primary outcome. Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592821/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37592821</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad511>10.1093/eurheartj/ehad511</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592821</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alexandra C van Dissel</dc:creator>
<dc:creator>Alexander R Opotowsky</dc:creator>
<dc:creator>Luke J Burchill</dc:creator>
<dc:creator>Jamil Aboulhosn</dc:creator>
<dc:creator>Jasmine Grewal</dc:creator>
<dc:creator>Adam M Lubert</dc:creator>
<dc:creator>Petra Antonova</dc:creator>
<dc:creator>Sangeeta Shah</dc:creator>
<dc:creator>Timothy Cotts</dc:creator>
<dc:creator>Anitha S John</dc:creator>
<dc:creator>William Aaron Kay</dc:creator>
<dc:creator>Christopher DeZorzi</dc:creator>
<dc:creator>Anthony Magalski</dc:creator>
<dc:creator>Frank Han</dc:creator>
<dc:creator>David Baker</dc:creator>
<dc:creator>Joseph Kay</dc:creator>
<dc:creator>Elizabeth Yeung</dc:creator>
<dc:creator>Isabelle Vonder Muhll</dc:creator>
<dc:creator>Stephen Pylypchuk</dc:creator>
<dc:creator>Marissa C Kuo</dc:creator>
<dc:creator>Jeremy Nicolarsen</dc:creator>
<dc:creator>Berardo Sarubbi</dc:creator>
<dc:creator>Flavia Fusco</dc:creator>
<dc:creator>Susan M Jameson</dc:creator>
<dc:creator>Jonathan Cramer</dc:creator>
<dc:creator>Tripti Gupta</dc:creator>
<dc:creator>Pastora Gallego</dc:creator>
<dc:creator>Clare O'Donnell</dc:creator>
<dc:creator>Jane Hannah</dc:creator>
<dc:creator>Mikael Dellborg</dc:creator>
<dc:creator>Robert M Kauling</dc:creator>
<dc:creator>Salil Ginde</dc:creator>
<dc:creator>Eric V Krieger</dc:creator>
<dc:creator>Fred Rodriguez</dc:creator>
<dc:creator>Payam Dehghani</dc:creator>
<dc:creator>Shelby Kutty</dc:creator>
<dc:creator>Joshua Wong</dc:creator>
<dc:creator>William M Wilson</dc:creator>
<dc:creator>Carla P Rodriguez-Monserrate</dc:creator>
<dc:creator>Jolien Roos-Hesselink</dc:creator>
<dc:creator>David S Celermajer</dc:creator>
<dc:creator>Paul Khairy</dc:creator>
<dc:creator>Craig S Broberg</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study</dc:title>
<dc:identifier>pmid:37592821</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad511</dc:identifier>
</item>
<item>
<title>Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592753/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Prognosis after LSIE is determined by multiple factors, including vegetation size.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad507. doi: 10.1093/eurheartj/ehad507. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Even though vegetation size in infective endocarditis (IE) has been associated with embolic events (EEs) and mortality risk, it is unclear whether vegetation size associated with these potential outcomes is different in left-sided IE (LSIE). This study aimed to seek assessing the vegetation cut-off size as predictor of EE or 30-day mortality for LSIE and to determine risk predictors of these outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The European Society of Cardiology EURObservational Research Programme European Infective Endocarditis is a prospective, multicentre registry including patients with definite or possible IE throughout 2016-18. Cox multivariable logistic regression analysis was performed to assess variables associated with EE or 30-day mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There were 2171 patients with LSIE (women 31.5%). Among these affected patients, 459 (21.1%) had a new EE or died in 30 days. The cut-off value of vegetation size for predicting EEs or 30-day mortality was >;10 mm [hazard ratio (HR) 1.38, 95% confidence interval (CI) 1.13-1.69, P = .0015]. Other adjusted predictors of risk of EE or death were as follows: EE on admission (HR 1.89, 95% CI 1.54-2.33, P &lt; .0001), history of heart failure (HR 1.53, 95% CI 1.21-1.93, P = .0004), creatinine >;2 mg/dL (HR 1.59, 95% CI 1.25-2.03, P = .0002), Staphylococcus aureus (HR 1.36, 95% CI 1.08-1.70, P = .008), congestive heart failure (HR 1.40, 95% CI 1.12-1.75, P = .003), presence of haemorrhagic stroke (HR 4.57, 95% CI 3.08-6.79, P &lt; .0001), alcohol abuse (HR 1.45, 95% CI 1.04-2.03, P = .03), presence of cardiogenic shock (HR 2.07, 95% CI 1.29-3.34, P = .003), and not performing left surgery (HR 1.30 95% CI 1.05-1.61, P = .016) (C-statistic = .68).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Prognosis after LSIE is determined by multiple factors, including vegetation size.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592753/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37592753</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad507>10.1093/eurheartj/ehad507</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592753</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Antonia Sambola</dc:creator>
<dc:creator>Jordi Lozano-Torres</dc:creator>
<dc:creator>Eric Boersma</dc:creator>
<dc:creator>Carmen Olmos</dc:creator>
<dc:creator>Julien Ternacle</dc:creator>
<dc:creator>Francisco Calvo</dc:creator>
<dc:creator>Christophe Tribouilloy</dc:creator>
<dc:creator>Vlatka Reskovic-Luksic</dc:creator>
<dc:creator>Jadranka Separovic-Hanzevacki</dc:creator>
<dc:creator>Seung-Woo Park</dc:creator>
<dc:creator>Sebastiaan Bekkers</dc:creator>
<dc:creator>Kwan-Leung Chan</dc:creator>
<dc:creator>Abdallah Almaghraby</dc:creator>
<dc:creator>Bernard Iung</dc:creator>
<dc:creator>Patrizio Lancellotti</dc:creator>
<dc:creator>Gilbert Habib</dc:creator>
<dc:creator>ESC EORP EURO-ENDO Registry Investigator Group</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry</dc:title>
<dc:identifier>pmid:37592753</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad507</dc:identifier>
</item>
<item>
<title>Congenitally corrected transposition of the great arteries: have we shifted the disease 'trajectory?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592741/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad482. doi: 10.1093/eurheartj/ehad482. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592741/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37592741</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad482>10.1093/eurheartj/ehad482</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592741</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Magalie Ladouceur</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Congenitally corrected transposition of the great arteries: have we shifted the disease 'trajectory?</dc:title>
<dc:identifier>pmid:37592741</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad482</dc:identifier>
</item>
<item>
<title>The projection-specific signals that establish functionally segregated dopaminergic synapses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37591240/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>Dopaminergic projections regulate various brain functions and are implicated in many neuropsychiatric disorders. There are two anatomically and functionally distinct dopaminergic projections connecting the midbrain to striatum: nigrostriatal, which controls movement, and mesolimbic, which regulates motivation. However, how these discrete dopaminergic synaptic connections are established is unknown. Through an unbiased search, we identify that two groups of antagonistic TGF-β family members, bone...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 9:S0092-8674(23)00801-2. doi: 10.1016/j.cell.2023.07.023. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dopaminergic projections regulate various brain functions and are implicated in many neuropsychiatric disorders. There are two anatomically and functionally distinct dopaminergic projections connecting the midbrain to striatum: nigrostriatal, which controls movement, and mesolimbic, which regulates motivation. However, how these discrete dopaminergic synaptic connections are established is unknown. Through an unbiased search, we identify that two groups of antagonistic TGF-β family members, bone morphogenetic protein (BMP)6/BMP2 and transforming growth factor (TGF)-β2, regulate dopaminergic synapse development of nigrostriatal and mesolimbic neurons, respectively. Projection-preferential expression of their receptors contributes to specific synapse development. Downstream, Smad1 and Smad2 are specifically activated and required for dopaminergic synapse development and function in nigrostriatal vs. mesolimbic projections. Remarkably, Smad1 mutant mice show motor defects, whereas Smad2 mutant mice show lack of motivation. These results uncover the molecular logic underlying the proper establishment of functionally segregated dopaminergic synapses and may provide strategies to treat relevant, projection-specific disease symptoms by targeting specific BMPs/TGF-β and/or Smads.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37591240/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37591240</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.023>10.1016/j.cell.2023.07.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37591240</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Akiko Terauchi</dc:creator>
<dc:creator>Patricia Yee</dc:creator>
<dc:creator>Erin M Johnson-Venkatesh</dc:creator>
<dc:creator>Mariel P Seiglie</dc:creator>
<dc:creator>Lisa Kim</dc:creator>
<dc:creator>Julia C Pitino</dc:creator>
<dc:creator>Eli Kritzer</dc:creator>
<dc:creator>Qiyu Zhang</dc:creator>
<dc:creator>Jie Zhou</dc:creator>
<dc:creator>Yulong Li</dc:creator>
<dc:creator>David D Ginty</dc:creator>
<dc:creator>Wei-Chung A Lee</dc:creator>
<dc:creator>Hisashi Umemori</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The projection-specific signals that establish functionally segregated dopaminergic synapses</dc:title>
<dc:identifier>pmid:37591240</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.023</dc:identifier>
</item>
<item>
<title>Atlas of the aging mouse brain reveals white matter as vulnerable foci</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37591239/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>Aging is the key risk factor for cognitive decline, yet the molecular changes underlying brain aging remain poorly understood. Here, we conducted spatiotemporal RNA sequencing of the mouse brain, profiling 1,076 samples from 15 regions across 7 ages and 2 rejuvenation interventions. Our analysis identified a brain-wide gene signature of aging in glial cells, which exhibited spatially defined changes in magnitude. By integrating spatial and single-nucleus transcriptomics, we found that glial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 8:S0092-8674(23)00805-X. doi: 10.1016/j.cell.2023.07.027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Aging is the key risk factor for cognitive decline, yet the molecular changes underlying brain aging remain poorly understood. Here, we conducted spatiotemporal RNA sequencing of the mouse brain, profiling 1,076 samples from 15 regions across 7 ages and 2 rejuvenation interventions. Our analysis identified a brain-wide gene signature of aging in glial cells, which exhibited spatially defined changes in magnitude. By integrating spatial and single-nucleus transcriptomics, we found that glial aging was particularly accelerated in white matter compared with cortical regions, whereas specialized neuronal populations showed region-specific expression changes. Rejuvenation interventions, including young plasma injection and dietary restriction, exhibited distinct effects on gene expression in specific brain regions. Furthermore, we discovered differential gene expression patterns associated with three human neurodegenerative diseases, highlighting the importance of regional aging as a potential modulator of disease. Our findings identify molecular foci of brain aging, providing a foundation to target age-related cognitive decline.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37591239/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37591239</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.027>10.1016/j.cell.2023.07.027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37591239</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Oliver Hahn</dc:creator>
<dc:creator>Aulden G Foltz</dc:creator>
<dc:creator>Micaiah Atkins</dc:creator>
<dc:creator>Blen Kedir</dc:creator>
<dc:creator>Patricia Moran-Losada</dc:creator>
<dc:creator>Ian H Guldner</dc:creator>
<dc:creator>Christy Munson</dc:creator>
<dc:creator>Fabian Kern</dc:creator>
<dc:creator>Róbert Pálovics</dc:creator>
<dc:creator>Nannan Lu</dc:creator>
<dc:creator>Hui Zhang</dc:creator>
<dc:creator>Achint Kaur</dc:creator>
<dc:creator>Jacob Hull</dc:creator>
<dc:creator>John R Huguenard</dc:creator>
<dc:creator>Sebastian Grönke</dc:creator>
<dc:creator>Benoit Lehallier</dc:creator>
<dc:creator>Linda Partridge</dc:creator>
<dc:creator>Andreas Keller</dc:creator>
<dc:creator>Tony Wyss-Coray</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Atlas of the aging mouse brain reveals white matter as vulnerable foci</dc:title>
<dc:identifier>pmid:37591239</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.027</dc:identifier>
</item>
<item>
<title>Histopathology of atrial fibrillation: does this help us understand its pathogenesis?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590445/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 17:ehad515. doi: 10.1093/eurheartj/ehad515. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590445/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37590445</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad515>10.1093/eurheartj/ehad515</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590445</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Rika Kawakami</dc:creator>
<dc:creator>Aloke V Finn</dc:creator>
<dc:creator>Renu Virmani</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Histopathology of atrial fibrillation: does this help us understand its pathogenesis?</dc:title>
<dc:identifier>pmid:37590445</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad515</dc:identifier>
</item>
<item>
<title>Danicamtiv Recruits Myosin Motors to Aid the Failing Heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590375/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18;133(5):444-446. doi: 10.1161/CIRCRESAHA.123.323366. Epub 2023 Aug 17.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590375/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37590375</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323366>10.1161/CIRCRESAHA.123.323366</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590375</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Maicon Landim-Vieira</dc:creator>
<dc:creator>Bjorn C Knollmann</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Danicamtiv Recruits Myosin Motors to Aid the Failing Heart</dc:title>
<dc:identifier>pmid:37590375</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323366</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18;133(5):374-375. doi: 10.1161/RES.0000000000000629. Epub 2023 Aug 17.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37590374</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000629>10.1161/RES.0000000000000629</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590374</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37590374</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000629</dc:identifier>
</item>
<item>
<title>Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37589160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: By maintaining endothelial mitochondrial homeostasis, deSUMOylation of FIS1 adaptively preserves pulmonary endothelial function against hypoxic stress and consequently protects against PH. The FIS1 deSUMOylation-SUMOylation transition in pulmonary endothelium is an intrinsic pathogenesis of hypoxic PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypoxia is a major cause and promoter of pulmonary hypertension (PH), a representative vascular remodeling disease with poor prognosis and high mortality. However, the mechanism underlying how pulmonary arterial system responds to hypoxic stress during PH remains unclear. Endothelial mitochondria are considered signaling organelles on oxygen tension. Results from previous clinical research and our studies suggested a potential role of posttranslational SUMOylation in endothelial mitochondria in hypoxia-related vasculopathy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Chronic hypoxia mouse model and Sugen/hypoxia rat model were employed as PH animal models. Mitochondrial morphology and subcellular structure were determined by transmission electron and immunofluorescent microscopies. Mitochondrial metabolism was determined by mitochondrial oxygen consumption rate and extracellular acidification rate. SUMOylation and protein interaction were determined by immunoprecipitation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The involvement of SENP1 (sentrin-specific protease 1)-mediated SUMOylation in mitochondrial remodeling in the pulmonary endothelium was identified in clinical specimens of hypoxia-related PH and was verified in human pulmonary artery endothelial cells under hypoxia. Further analyses in clinical specimens, hypoxic rat and mouse PH models, and human pulmonary artery endothelial cells and human embryonic stem cell-derived endothelial cells revealed that short-term hypoxia-induced SENP1 translocation to endothelial mitochondria to regulate deSUMOylation of mitochondrial fission protein FIS1 (mitochondrial fission 1), which facilitated FIS1 assembling with fusion protein MFN2 (mitofusin 2) and mitochondrial gatekeeper VDAC1 (voltage-dependent anion channel 1), and the membrane tethering activity of MFN2 by enhancing its oligomerization. Consequently, FIS1 deSUMOylation maintained the mitochondrial integrity and endoplasmic reticulum-mitochondria calcium communication across mitochondrial-associated membranes, subsequently preserving pulmonary endothelial function and vascular homeostasis. In contrast, prolonged hypoxia disabled the FIS1 deSUMOylation by diminishing the availability of SENP1 in mitochondria via inducing miR-138 and consequently resulted in mitochondrial dysfunction and metabolic reprogramming in pulmonary endothelium. Functionally, introduction of viral-packaged deSUMOylated FIS1 within pulmonary endothelium in mice improved pulmonary endothelial dysfunction and hypoxic PH development, while knock-in of SUMO (small ubiquitin-like modifier)-conjugated FIS1 in mice exaggerated the diseased cellular and tissue phenotypes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: By maintaining endothelial mitochondrial homeostasis, deSUMOylation of FIS1 adaptively preserves pulmonary endothelial function against hypoxic stress and consequently protects against PH. The FIS1 deSUMOylation-SUMOylation transition in pulmonary endothelium is an intrinsic pathogenesis of hypoxic PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37589160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37589160</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.122.321200>10.1161/CIRCRESAHA.122.321200</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37589160</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Xiaofei Zhou</dc:creator>
<dc:creator>Yuanqing Jiang</dc:creator>
<dc:creator>Yuewen Wang</dc:creator>
<dc:creator>Linge Fan</dc:creator>
<dc:creator>Yunhui Zhu</dc:creator>
<dc:creator>Yefeng Chen</dc:creator>
<dc:creator>Yiran Wang</dc:creator>
<dc:creator>Yingyi Zhu</dc:creator>
<dc:creator>Hongkun Wang</dc:creator>
<dc:creator>Zihang Pan</dc:creator>
<dc:creator>Zhoubin Li</dc:creator>
<dc:creator>Xiaolong Zhu</dc:creator>
<dc:creator>Ruizhe Ren</dc:creator>
<dc:creator>Zhen Ge</dc:creator>
<dc:creator>Dongwu Lai</dc:creator>
<dc:creator>En-Yin Lai</dc:creator>
<dc:creator>Ting Chen</dc:creator>
<dc:creator>Kai Wang</dc:creator>
<dc:creator>Ping Liang</dc:creator>
<dc:creator>Lingfeng Qin</dc:creator>
<dc:creator>Cuiqing Liu</dc:creator>
<dc:creator>Cong Qiu</dc:creator>
<dc:creator>Michael Simons</dc:creator>
<dc:creator>Luyang Yu</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:37589160</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.122.321200</dc:identifier>
</item>
<item>
<title>Extravalvular Myocardial Damage and Aortic Valve Replacement</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587588/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):e67. doi: 10.1016/j.jacc.2023.04.061.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587588/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587588</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.061>10.1016/j.jacc.2023.04.061</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587588</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Ahmed Elkaryoni</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Extravalvular Myocardial Damage and Aortic Valve Replacement</dc:title>
<dc:identifier>pmid:37587588</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.061</dc:identifier>
</item>
<item>
<title>Long-Term Clinical Consequences of Right Ventricular Remodeling in Olympic Endurance Athletes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587587/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):750-751. doi: 10.1016/j.jacc.2023.04.060.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587587/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587587</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.04.060>10.1016/j.jacc.2023.04.060</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587587</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Antonio Pelliccia</dc:creator>
<dc:creator>Roberto Ferrara</dc:creator>
<dc:creator>Silvia Prosperi</dc:creator>
<dc:creator>Antonio Spataro</dc:creator>
<dc:creator>Viviana Maestrini</dc:creator>
<dc:creator>Maria Rosaria Squeo</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Long-Term Clinical Consequences of Right Ventricular Remodeling in Olympic Endurance Athletes</dc:title>
<dc:identifier>pmid:37587587</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.04.060</dc:identifier>
</item>
<item>
<title>Challenges to Science, Health, and Education as Contributors to Progress: A Call to the Young Generation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587586/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):748-749. doi: 10.1016/j.jacc.2023.07.002.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587586/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587586</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.07.002>10.1016/j.jacc.2023.07.002</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587586</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Valentin Fuster</dc:creator>
<dc:creator>Justine Varieur Turco</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Challenges to Science, Health, and Education as Contributors to Progress: A Call to the Young Generation</dc:title>
<dc:identifier>pmid:37587586</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.07.002</dc:identifier>
</item>
<item>
<title>Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587585/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>Nonischemic cardiomyopathy (NICM) is common and patients are at significant risk for early mortality secondary to ventricular arrhythmias. Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy to decrease sudden cardiac death (SCD) in patients with heart failure and reduced left ventricular ejection fraction. However, in randomized clinical trials comprised solely of patients with NICM, primary prevention ICDs did not confer significant mortality benefit. Moreover,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):735-747. doi: 10.1016/j.jacc.2023.05.064.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Nonischemic cardiomyopathy (NICM) is common and patients are at significant risk for early mortality secondary to ventricular arrhythmias. Current guidelines recommend implantable cardioverter-defibrillator (ICD) therapy to decrease sudden cardiac death (SCD) in patients with heart failure and reduced left ventricular ejection fraction. However, in randomized clinical trials comprised solely of patients with NICM, primary prevention ICDs did not confer significant mortality benefit. Moreover, left ventricular ejection fraction has limited sensitivity and specificity for predicting SCD. Therefore, precise risk stratification algorithms are needed to define those at the highest risk of SCD. This review examines mechanisms of sudden arrhythmic death in patients with NICM, discusses the role of ICD therapy and treatment of heart failure for prevention of SCD in patients with NICM, examines the role of cardiac magnetic resonance imaging and computational modeling for SCD risk stratification, and proposes new strategies to guide future clinical trials on SCD risk assessment in patients with NICM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587585/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587585</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.064>10.1016/j.jacc.2023.05.064</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587585</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jonathan Chrispin</dc:creator>
<dc:creator>Faisal M Merchant</dc:creator>
<dc:creator>Neal K Lakdawala</dc:creator>
<dc:creator>Katherine C Wu</dc:creator>
<dc:creator>Gordon F Tomaselli</dc:creator>
<dc:creator>Rachita Navara</dc:creator>
<dc:creator>Estelle Torbey</dc:creator>
<dc:creator>Amrut V Ambardekar</dc:creator>
<dc:creator>Rajesh Kabra</dc:creator>
<dc:creator>Eloisa Arbustini</dc:creator>
<dc:creator>Jagat Narula</dc:creator>
<dc:creator>Maya Guglin</dc:creator>
<dc:creator>Christine M Albert</dc:creator>
<dc:creator>Sumeet S Chugh</dc:creator>
<dc:creator>Natalia Trayanova</dc:creator>
<dc:creator>Jim W Cheung</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Risk of Arrhythmic Death in Patients With Nonischemic Cardiomyopathy: JACC Review Topic of the Week</dc:title>
<dc:identifier>pmid:37587585</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.064</dc:identifier>
</item>
<item>
<title>ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587584/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):721-734. doi: 10.1016/j.jacc.2023.05.061.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Valvular heart disease (VHD) is common and poses important challenges from the standpoints of diagnosis and therapeutic management. Clinical practice guidelines have been developed to help health care professionals to overcome these challenges and provide optimal management to patients with VHD. The American College of Cardiology, in collaboration with the American Heart Association, and the European Society of Cardiology, in collaboration with the European Association for Cardio-Thoracic Surgery, recently updated their guidelines on the management of VHD. Although these 2 sets of guidelines are generally concordant, there are some substantial differences between these guidelines, which may have significant implications for clinical practice. This review prepared on behalf of the EuroValve Consortium describes the consistencies and discrepancies between the guidelines and highlights the gaps in these guidelines and the future research perspectives to fill these gaps.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587584/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587584</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.061>10.1016/j.jacc.2023.05.061</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587584</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Augustin Coisne</dc:creator>
<dc:creator>Patrizio Lancellotti</dc:creator>
<dc:creator>Gilbert Habib</dc:creator>
<dc:creator>Madalina Garbi</dc:creator>
<dc:creator>Jordi Sanchez Dahl</dc:creator>
<dc:creator>Marco Barbanti</dc:creator>
<dc:creator>Mani A Vannan</dc:creator>
<dc:creator>Vassilios S Vassiliou</dc:creator>
<dc:creator>Dariusz Dudek</dc:creator>
<dc:creator>Ovidiu Chioncel</dc:creator>
<dc:creator>Johannes L Waltenberger</dc:creator>
<dc:creator>Victoria L Johnson</dc:creator>
<dc:creator>Ruggero De Paulis</dc:creator>
<dc:creator>Rodolfo Citro</dc:creator>
<dc:creator>Philippe Pibarot</dc:creator>
<dc:creator>EuroValve Consortium</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>ACC/AHA and ESC/EACTS Guidelines for the Management of Valvular Heart Diseases: JACC Guideline Comparison</dc:title>
<dc:identifier>pmid:37587584</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.061</dc:identifier>
</item>
<item>
<title>Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587583/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):718-720. doi: 10.1016/j.jacc.2023.06.009.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587583/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587583</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.009>10.1016/j.jacc.2023.06.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587583</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Maria Rosa Costanzo</dc:creator>
<dc:creator>Thomas H Marwick</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Right Atrium as Barometer of Right Ventricular Stiffness and Treatment Responsiveness in Precapillary Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:37587583</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.009</dc:identifier>
</item>
<item>
<title>Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587582/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: RA PV loops show increased RA stiffness and suggest atrioventricular uncoupling in patients with severe RV diastolic stiffness. Isolated RA cardiomyocytes of precPH patients are hypertrophied, without intrinsic sarcomeric changes. In end-stage precPH, reduced capillary density is accompanied by interstitial and perivascular fibrosis.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):704-717. doi: 10.1016/j.jacc.2023.05.063.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Precapillary pulmonary hypertension (precPH) patients have altered right atrial (RA) function and right ventricular (RV) diastolic stiffness.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVES: This study aimed to investigate RA function using pressure-volume (PV) loops, isolated cardiomyocyte, and histological analyses.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: RA PV loops were constructed in control subjects (n = 9) and precPH patients (n = 27) using magnetic resonance and catheterization data. RA stiffness (pressure rise during atrial filling) and right atrioventricular coupling index (RA minimal volume / RV end-diastolic volume) were compared in a larger cohort of patients with moderate (n = 39) or severe (n = 41) RV diastolic stiffness. Cardiomyocytes were isolated from RA tissue collected from control subjects (n = 6) and precPH patients (n = 9) undergoing surgery. Autopsy material was collected from control subjects (n = 6) and precPH patients (n = 4) to study RA hypertrophy, capillarization, and fibrosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: RA PV loops showed 3 RA cardiac phases (reservoir, passive emptying, and contraction) with dilatation and elevated pressure in precPH. PrecPH patients with severe RV diastolic stiffness had increased RA stiffness and worse right atrioventricular coupling index. Cardiomyocyte cross-sectional area was increased 2- to 3-fold in precPH, but active tension generated by the sarcomeres was unaltered. There was no increase in passive tension of the cardiomyocytes, but end-stage precPH showed reduced number of capillaries per mm<sup>2</sup> accompanied by interstitial and perivascular fibrosis.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: RA PV loops show increased RA stiffness and suggest atrioventricular uncoupling in patients with severe RV diastolic stiffness. Isolated RA cardiomyocytes of precPH patients are hypertrophied, without intrinsic sarcomeric changes. In end-stage precPH, reduced capillary density is accompanied by interstitial and perivascular fibrosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587582/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587582</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.05.063>10.1016/j.jacc.2023.05.063</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587582</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jeroen N Wessels</dc:creator>
<dc:creator>Jessie van Wezenbeek</dc:creator>
<dc:creator>Jari de Rover</dc:creator>
<dc:creator>Rowan Smal</dc:creator>
<dc:creator>Aida Llucià-Valldeperas</dc:creator>
<dc:creator>Lucas R Celant</dc:creator>
<dc:creator>J Tim Marcus</dc:creator>
<dc:creator>Lilian J Meijboom</dc:creator>
<dc:creator>Joanne A Groeneveldt</dc:creator>
<dc:creator>Frank P T Oosterveer</dc:creator>
<dc:creator>Toon A Winkelman</dc:creator>
<dc:creator>Hans W M Niessen</dc:creator>
<dc:creator>Marie-José Goumans</dc:creator>
<dc:creator>Harm Jan Bogaard</dc:creator>
<dc:creator>Anton Vonk Noordegraaf</dc:creator>
<dc:creator>Gustav J Strijkers</dc:creator>
<dc:creator>M Louis Handoko</dc:creator>
<dc:creator>Berend E Westerhof</dc:creator>
<dc:creator>Frances S de Man</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Right Atrial Adaptation to Precapillary Pulmonary Hypertension: Pressure-Volume, Cardiomyocyte, and Histological Analysis</dc:title>
<dc:identifier>pmid:37587582</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.05.063</dc:identifier>
</item>
<item>
<title>Is Risk Stratification for Bleeding and Ischemic Events Still Useful When De-Escalating to Ticagrelor Monotherapy?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37587581/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230818203338&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2023 Aug 22;82(8):701-703. doi: 10.1016/j.jacc.2023.06.010.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37587581/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230818203338&v=2.17.9.post6+86293ac">37587581</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2023.06.010>10.1016/j.jacc.2023.06.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37587581</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Puja B Parikh</dc:creator>
<dc:creator>Tullio Palmerini</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Is Risk Stratification for Bleeding and Ischemic Events Still Useful When De-Escalating to Ticagrelor Monotherapy?</dc:title>
<dc:identifier>pmid:37587581</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2023.06.010</dc:identifier>
</item>





























</channel>
</rss>